ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,838, issued on March 4, was assigned to BIOGEN MA INC. (Cambridge, Mass.).
"Inhibiting agents for Bruton's tyrosine kinase" was invented by Brian T. Hopkins (Cambridge, Mass.), Bin Ma (Cambridge, Mass.), Robin Prince (Cambridge, Mass.), Isaac Marx (Cambridge, Mass.), Jurgen Schulz (Cambridge, Mass.) and Marta Nevalainen (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production."
The patent was filed on May 15, 2020, under Application No. 17/610,963.
*For further information, including images, charts and tables, pleas...